Actively Recruiting
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
Led by Johns Hopkins University · Updated on 2025-11-18
42
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate mood changes in patients with Non-Muscle Invasive Bladder Cancer who are receiving intravesical Bacillus Calmete-Guerin (BCG). Patients with Non-Muscle Invasive Bladder Cancer receiving intravesical treatments are eligible to participate in this study. Participation involves providing research blood and urine samples prior to the start of treatment and throughout the treatment course. The study team will also collect participant's medical history and clinical information. Participants will be asked to complete questionnaires and daily mood diaries.
CONDITIONS
Official Title
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects with a pathologically confirmed non-muscle invasive bladder cancer
- Age 265 18 years old
- Ability to understand and willingness to sign a written informed consent document
You will not qualify if you...
- Patients not candidates for intravesical treatment due to disease nature, such as variant histology or progressive disease after prior intravesical treatment
- Patients who are pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sibley Memorial Hospital
Washington D.C., District of Columbia, United States, 20016
Actively Recruiting
Research Team
D
Domani Rodriguez
CONTACT
A
Armine Smith, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here